Literature DB >> 17914061

Updated research nosology for HIV-associated neurocognitive disorders.

A Antinori1, G Arendt, J T Becker, B J Brew, D A Byrd, M Cherner, D B Clifford, P Cinque, L G Epstein, K Goodkin, M Gisslen, I Grant, R K Heaton, J Joseph, K Marder, C M Marra, J C McArthur, M Nunn, R W Price, L Pulliam, K R Robertson, N Sacktor, V Valcour, V E Wojna.   

Abstract

In 1991, the AIDS Task Force of the American Academy of Neurology published nomenclature and research case definitions to guide the diagnosis of neurologic manifestations of HIV-1 infection. Now, 16 years later, the National Institute of Mental Health and the National Institute of Neurological Diseases and Stroke have charged a working group to critically review the adequacy and utility of these definitional criteria and to identify aspects that require updating. This report represents a majority view, and unanimity was not reached on all points. It reviews our collective experience with HIV-associated neurocognitive disorders (HAND), particularly since the advent of highly active antiretroviral treatment, and their definitional criteria; discusses the impact of comorbidities; and suggests inclusion of the term asymptomatic neurocognitive impairment to categorize individuals with subclinical impairment. An algorithm is proposed to assist in standardized diagnostic classification of HAND.

Entities:  

Mesh:

Year:  2007        PMID: 17914061      PMCID: PMC4472366          DOI: 10.1212/01.WNL.0000287431.88658.8b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  G J Dore; P K Correll; Y Li; J M Kaldor; D A Cooper; B J Brew
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

2.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

3.  Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  Gregory J Dore; Ann McDonald; Yueming Li; John M Kaldor; Bruce J Brew
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

Review 4.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

5.  A multimodal assessment of driving performance in HIV infection.

Authors:  T D Marcotte; T Wolfson; T J Rosenthal; R K Heaton; R Gonzalez; R J Ellis; I Grant
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

6.  Motor analysis predicts progression in HIV-associated brain disease.

Authors:  G Arendt; H Hefter; F Hilperath; H J von Giesen; G Strohmeyer; H J Freund
Journal:  J Neurol Sci       Date:  1994-05       Impact factor: 3.181

7.  Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS.

Authors:  S C Kalichman; D Rompa; M Cage
Journal:  J Nerv Ment Dis       Date:  2000-10       Impact factor: 2.254

8.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors:  M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

9.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

10.  HIV Dementia Scale: a rapid screening test.

Authors:  C Power; O A Selnes; J A Grim; J C McArthur
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-03-01
View more
  1287 in total

Review 1.  Molecular Imaging of Neuroinflammation in HIV.

Authors:  Anna Boerwinkle; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

2.  Empiric neurocognitive performance profile discovery and interpretation in HIV infection.

Authors:  Daniela Gomez; Christopher Power; M John Gill; Noshin Koenig; Roberto Vega; Esther Fujiwara
Journal:  J Neurovirol       Date:  2018-12-05       Impact factor: 2.643

Review 3.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

4.  Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives.

Authors:  Albert M Anderson; Theresa N Schein; Aley Kalapila; Lillin Lai; Drenna Waldrop-Valverde; Raeanne C Moore; Donald Franklin; Scott L Letendre; Scott R Barnum
Journal:  J Neuroimmunol       Date:  2017-07-23       Impact factor: 3.478

5.  Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

Authors:  K Robertson; H Jiang; J Kumwenda; K Supparatpinyo; S Evans; T B Campbell; R Price; S Tripathy; N Kumarasamy; A La Rosa; B Santos; M T Silva; S Montano; C Kanyama; S Faesen; R Murphy; C Hall; C M Marra; C Marcus; B Berzins; R Allen; M Housseinipour; F Amod; I Sanne; J Hakim; A Walawander; A Nair
Journal:  Clin Infect Dis       Date:  2012-06-01       Impact factor: 9.079

6.  Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

Authors:  Jose A Muñoz-Moreno; Carmina R Fumaz; Anna Prats; Maria J Ferrer; Eugènia Negredo; Núria Pérez-Alvarez; José Moltó; Guadalupe Gómez; Maite Garolera; Bonaventura Clotet
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

7.  Cognitive disorders in HIV-infected and AIDS patients in Guangxi, China.

Authors:  Tingting Zhao; Bo Wei; Jianxiong Long; Xianyan Tang; Mengxiao Zhou; Chao Dang
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

8.  Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction.

Authors:  Michael Ditiatkovski; Nigora Mukhamedova; Dragana Dragoljevic; Anh Hoang; Hann Low; Tatiana Pushkarsky; Ying Fu; Irena Carmichael; Andrew F Hill; Andrew J Murphy; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

9.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

10.  HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.

Authors:  N S Ku; Y Lee; J Y Ahn; J E Song; M H Kim; S B Kim; S J Jeong; K-W Hong; E Kim; S H Han; J Y Song; H J Cheong; Y G Song; W J Kim; J M Kim; D M Smith; J Y Choi
Journal:  HIV Med       Date:  2014-02-24       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.